Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-28

Clinical Trial Update: The Effects of Nicotine on Cognition in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effects of nicotine on cognition in individuals with schizophrenia; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine (nicotine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2017-04-28